Among the long questions the pandemic left behind is how young bodies weigh the virus against its vaccine, and a large study drawn from nearly every child in England now offers a clearer answer. Across records of roughly fourteen million young people, the researchers found that the rare heart and inflammatory complications that follow COVID-19 infection outnumber those that follow vaccination, and that the infection's shadow lingers for months rather than weeks. The authors are careful to note that both kinds of risk remain uncommon, and that the future of the virus is still unwritten, so the
Children Face Higher Heart Risks From COVID-19 Infection Than From Vaccination, English Study Finds
Children after COVID-19 infection faced elevated risks of myocarditis, pericarditis, blood clots, and low platelet counts, with effects lasting up to a year.
Rare either way, but the risk after infection lasted far longer
Mark
Start with the headline finding. Infection carries more risk than the vaccine for children?
Mimi
Yes, for these rare heart and inflammatory conditions. Over six months, infection caused 2.24 extra cases of heart inflammation per 100,000 children, against 0.85 after vaccination.
Mark
And the timing differs too.
Mimi
Quite a bit. Vaccine-linked myocarditis risk lasted about four weeks. After infection, risk peaked in the first four weeks but stayed elevated for up to a year.
Luke
Worth saying the scale. Both risks are rare. These are extra cases per 100,000, not a statement that many children were harmed.
Mark
How solid is the dataset?
Mimi
It covers nearly 14 million under-18s, about 98 percent of the population, using linked health records from January 2020 to December 2022.
Luke
Though it's retrospective, observational work. It shows association in records, and the source doesn't detail how they handled differences between infected and vaccinated children.
Mark
Does it cover every vaccine?
Mimi
The reporting names the Pfizer-BioNTech vaccine specifically.
Luke
So I wouldn't stretch it to other vaccines. And the study period ended in 2022. Professor Wood herself says infection risks could change with new variants, so this is not a forecast.
Der Puls
- A rare but serious threat, inflammation of the heart muscle, hung over young people throughout the pandemic and demanded a clear comparison.
- Infection stirred the deepest unrest: its heart and blood-related risks spiked within four weeks and stayed elevated for up to a year.
- Vaccine-linked myocarditis proved a brief, far smaller ripple, lasting roughly four weeks after a dose.
- Researchers are steering vaccine policy by weighing these numbers against one another, while watching whether new variants will change the picture.
- The verdict so far points toward infection carrying the greater burden, though the trajectory depends on how the virus evolves.
Among the long questions the pandemic left behind is how young bodies weigh the virus against its vaccine, and a large study drawn from nearly every child in England now offers a clearer answer. Across records of roughly fourteen million young people, the researchers found that the rare heart and inflammatory complications that follow COVID-19 infection outnumber those that follow vaccination, and that the infection's shadow lingers for months rather than weeks. The authors are careful to note that both kinds of risk remain uncommon, and that the future of the virus is still unwritten, so the evidence is best read as a guide for ongoing vigilance rather than a final verdict.
The study drew on health records covering nearly 14 million children and young people in England, roughly 98 percent of everyone under nineteen in the country. Researchers wanted to answer a question that had lingered since the pandemic began: for young people, which carries greater risk of rare heart and inflammatory complications, catching COVID-19 or receiving the vaccine?
The answer, published in The Lancet Child and Adolescent Health, points to infection. Between 2020 and 2022, about 3.9 million of these children were diagnosed with COVID-19 and about 3.4 million were vaccinated. The team tracked conditions including myocarditis and pericarditis, which are inflammation of the heart muscle and surrounding tissue, along with blood clots, low platelet counts, and other inflammatory conditions.
After infection, the risks peaked within the first four weeks and remained elevated for as long as a year. The Pfizer-BioNTech vaccine slightly raised the risk of heart inflammation, but only for about four weeks, and by a much smaller margin. Over six months, COVID-19 caused 2.24 extra cases of heart inflammation per 100,000 children, compared with 0.85 per 100,000 after vaccination. The study does not dispute that rare vaccine-linked myocarditis occurs; it places that risk beside the one from the virus.
The work was led by Dr. Alexia Sampri of the University of Cambridge, with senior authors Prof. William N. Whiteley and Prof. Angela M. Wood. Sampri emphasized that although these outcomes are rare, young people were more likely to suffer heart, vascular or inflammatory problems after infection, and those effects lasted far longer.
Prof. Wood cautioned that vaccine risks are likely to remain rare and brief, while the risks from infection could shift as new variants emerge and immunity changes. Continued monitoring of whole-population health data, she said, will remain essential for guiding vaccine and public health decisions. The findings give policymakers firmer ground for weighing infection against vaccination in younger people, but how those infection risks evolve as the virus changes is still an open question.
The records covered nearly 14 million children and young people in England, aged 18 and under, about 98 percent of that population. Researchers used them to ask a question that has hung over the pandemic years: for young people, which carries the greater risk of rare heart and inflammatory complications, catching COVID-19 or being vaccinated against it?
Their answer, published in The Lancet Child and Adolescent Health, is that infection does. The study describes itself as the largest of its kind. Its full title is "Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records."
The window ran from January 2020 to December 2022. In that time roughly 3.9 million of these children were diagnosed with COVID-19, and about 3.4 million received the vaccine. The researchers looked at five conditions: inflammatory conditions, blood clots, low platelet counts, and myocarditis and pericarditis, which are inflammation of the heart muscle and of the tissue surrounding the heart. Myocarditis can impair the heart's ability to pump blood effectively.
After a first infection, the risk of those conditions peaked in the first four weeks. It then stayed elevated for up to 12 months, compared with children who had not been infected. The Pfizer-BioNTech vaccine, by contrast, slightly raised the risk of myocarditis or pericarditis for about four weeks, and the increase was far smaller than the one tied to infection.
The figures put numbers on that gap. Over six months, COVID-19 caused 2.24 extra cases of heart inflammation per 100,000 children. After vaccination, the figure was 0.85 per 100,000. Rare cases of myocarditis have been reported in young people shortly after mRNA-based vaccines, and the study does not dispute that. It places that risk next to the one from the virus itself.
The work was led by Dr. Alexia Sampri of the University of Cambridge's Cardiovascular Epidemiology Unit. Co-authors include Wen Shi, Thomas Bolton, Samantha Ip, Rochelle Knight, Venexia Walker, Rachel Denholm, Elena Raffetti, Spencer Keene, Elias Allara and Xiyun Jiang. Senior authors include Prof. William N. Whiteley and Prof. Angela M. Wood. The team represents the CVD-COVID-UK/COVID-IMPACT Consortium and the Longitudinal Health Wellbeing COVID-19 National Core Study.
Sampri said the whole-population study showed that although these conditions were rare, children and young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection than after vaccination, and that the risks after infection lasted much longer.
Prof. Wood added a caution about the future. Vaccine-related risks are likely to remain rare and short-lived, she said, but risks following infection could change as new variants emerge and immunity shifts. For that reason, she said, monitoring health data across whole populations remains essential to guide vaccine and other public health decisions. The authors say the findings give policymakers firmer data for weighing infection against vaccination in younger people, and the open question is how those infection risks hold up as the virus changes.
Bemerkenswerte Zitate
Although these conditions were rare, children and young people were more likely to experience heart, vascular, or inflammatory problems after a COVID-19 infection than after having the vaccine, and the risks after infection lasted much longer.— Dr. Alexia Sampri, University of Cambridge
Future risks following infection could change as new variants emerge and immunity shifts, so whole-population health data monitoring remains essential.— Prof. Angela Wood, co-author (paraphrased)
Möchten Sie die ganze Geschichte?
Das Original lesen bei The Economic Times ↗
Health & Medicine